Company Filing History:
1 out of 3,539 
1 out of 832,843 Years Active: 2013-2014
Title: Marc Nicklaus: Innovator in Hepatocyte Growth Factor Receptor Research
Introduction
Marc Nicklaus is a notable inventor based in Catonsville, MD (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the inhibition of hepatocyte growth factor receptor c-Met signaling. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Marc Nicklaus's latest patents focus on compositions and methods for inhibiting hepatocyte growth factor receptor c-Met signaling. The first patent details derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met, along with pharmaceutical compositions containing these derivatives. It also outlines methods for making these derivatives and their applications. The second patent similarly addresses derivatives and analogs obtained through virtual screening, providing a comprehensive approach to c-Met inhibitors and their pharmaceutical uses.
Career Highlights
Throughout his career, Marc has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His research has been pivotal in advancing the understanding of c-Met signaling pathways and their potential therapeutic targets.
Collaborations
Marc has collaborated with notable colleagues, including Donald P Bottaro and Megan Peach. Their combined expertise has contributed to the successful development of innovative solutions in the field of receptor tyrosine kinase research.
Conclusion
Marc Nicklaus stands out as an influential inventor in the realm of pharmaceutical research, particularly in the inhibition of c-Met signaling. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.